No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: a cancer registry linkage study

K. Bedair, A. Elhadad, S. Hamad, J. Ferguson, P. Donnan, R. S. Dawe (Lead / Corresponding author)

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)
15 Downloads (Pure)

Abstract

Ultraviolet A1 (UVA1) phototherapy was first developed in the 1980s.1 Its use started in the UK in Dundee in 1996.2 It is not available in most centres despite being useful for some of the sclerosing/fibrosing conditions and granulomatous conditions. Where available, for some individuals, it can be very helpful for other indications such as atopic eczema.3 A concern is that sufficient exposures might increase the risk of skin cancer.4 Itt has been shown to produce cyclobutane-pyrimidine dimers in humans,5 and so has the potential to be carcinogenic.

Original languageEnglish
Pages (from-to)586-587
Number of pages2
JournalBritish Journal of Dermatology
Volume183
Issue number3
Early online date20 Mar 2020
DOIs
Publication statusPublished - 1 Sep 2020

Fingerprint

Dive into the research topics of 'No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: a cancer registry linkage study'. Together they form a unique fingerprint.

Cite this